2014
DOI: 10.5858/arpa.2013-0263-oa
|View full text |Cite
|
Sign up to set email alerts
|

A Framework for Evaluating Diagnostic Discordance in Pathology Discovered During Research Studies

Abstract: Context Little is known about the frequency of discordant diagnoses identified during research. Objective To describe diagnostic discordance identified during research and apply a newly designed research framework for investigating discordance. Design Breast biopsy cases (N =407) from registries in Vermont and New Hampshire were independently reviewed by a breast pathology expert. The following research framework was developed to assess those cases: (1) compare the expert review and study database diagnose… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
11
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
2

Relationship

4
4

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 18 publications
(12 reference statements)
0
11
0
Order By: Relevance
“…[24252627] Briefly, 240 breast biopsy specimens were randomly selected from pathology registries. Each case included standardized data on the woman's age at biopsy, breast density, and biopsy type.…”
Section: Methodsmentioning
confidence: 99%
“…[24252627] Briefly, 240 breast biopsy specimens were randomly selected from pathology registries. Each case included standardized data on the woman's age at biopsy, breast density, and biopsy type.…”
Section: Methodsmentioning
confidence: 99%
“…20,21 The methods and test sets developed for the B-Path study are described elsewhere. 22,23 In brief, each of four tests sets (A, B, C, and D) of breast biopsy specimens were created after sampling registries in Vermont and New Hampshire associated with the Breast Cancer Surveillance Consortium. 24 Each test set was composed of 60 cases, one glass slide per case, randomized with stratification (N=240) to contain comparable pathological findings.…”
Section: Methodsmentioning
confidence: 99%
“…The breast pathology (B-Path) and digital pathology (digiPATH) study [41][42][43][44] aims are to understand the diagnostic patterns of pathologists and evaluate the accuracy and efficiency of interpretations using glass slides and digital whole slide images. For this purpose, three expert pathologists were invited to interpret a series of 240 breast biopsies on glass or digital media.…”
Section: Datasetmentioning
confidence: 99%
“…Cases included benign without atypia (30 %), atypical ductal hyperplasia (30 %), ductal carcinoma in situ (30 %), and invasive breast cancer (10 %). The methods of case development and data collection from pathologists have been previously described [41][42][43][44] and will be summarized here briefly.…”
Section: Datasetmentioning
confidence: 99%